First patient randomized in an international double-blind Phase III cardiac surgery study

The study, sponsored by a European biopharmaceutical company and managed by GCT in Russia has got off the ground.  Recently, the leading Russian Cardiology Institute has randomized the first patient in the study.

November 13, 2018

Swift enrollment completion for a phase II study

An International Multicenter Phase II study in Patients with Non-Hodgkin lymphoma is currently ongoing in 6 countries, including Ukraine that was recently initiated by GCT.

October 5, 2018

Enrollment launches for Phase II study in patients with Non-Hodgkin lymphoma

The International Multicenter study is currently ongoing in 6 countries, including Ukraine that was recently initiated by GCT.

August 13, 2018